Which has stronger valuation & earnings, IRIX or MDAI?

IRIDEX has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.24 -$4.44M -$0.20 N/A Spectral AI $19.65M 2.57 -$7.57M -$0.35 N/A

Is IRIX or MDAI more profitable?

IRIDEX has a net margin of -6.88% compared to Spectral AI's net margin of -69.27%. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Spectral AI -69.27% N/A -78.56%

Do analysts rate IRIX or POCI?

IRIDEX currently has a consensus price target of $3.00, suggesting a potential upside of 314.59%. Given IRIDEX's stronger consensus rating and higher probable upside, equities research analysts plainly believe IRIDEX is more favorable than Precision Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is IRIX or POCI more profitable?

IRIDEX has a net margin of -6.88% compared to Precision Optics' net margin of -17.03%. IRIDEX's return on equity of 0.00% beat Precision Optics' return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Precision Optics -17.03% -37.47% -19.96%

Do analysts rate BDMD or IRIX?

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 314.59%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, BDMD or IRIX?

Baird Medical Investment has higher earnings, but lower revenue than IRIDEX. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 2.06 N/A N/A N/A IRIDEX $52.67M 0.24 -$4.44M -$0.20 N/A

Is BDMD or IRIX more profitable?

Baird Medical Investment has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A IRIDEX -6.88% N/A -12.55%

Is IRIX or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.88%. Sanuwave Health's return on equity of 1,728.10% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Sanuwave Health 32.38% 1,728.10% 39.04%

IRIDEX (IRIX) Competitors

$0.72 +0.02 (+2.42%)

Closing price 08/31/2026 04:00 PM Eastern

Extended Trading

$0.72 -0.01 (-1.05%)

As of 04:00 AM Eastern

Compare

IRIX vs. MDAI, SRTS, POCI, BDMD, and SNWV

Should you buy IRIDEX stock or one of its competitors? IRIDEX's main competitors and comparable companies include Spectral AI (MDAI), Sensus Healthcare (SRTS), Precision Optics (POCI), Baird Medical Investment (BDMD), and Sanuwave Health (SNWV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does IRIDEX compare to Spectral AI?

IRIDEX (NASDAQ:IRIX) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

In the previous week, IRIDEX and IRIDEX both had 1 articles in the media. Spectral AI's average media sentiment score of 1.89 beat IRIDEX's score of 0.44 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Neutral
Spectral AI	Very Positive

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 314.59%. Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 154.78%. Given IRIDEX's higher probable upside, research analysts clearly believe IRIDEX is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

IRIDEX has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.24	-$4.44M	-$0.20	N/A
Spectral AI	$19.65M	2.57	-$7.57M	-$0.35	N/A

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

IRIDEX has a net margin of -6.88% compared to Spectral AI's net margin of -69.27%.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Spectral AI	-69.27%	N/A	-78.56%

IRIDEX has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Summary

IRIDEX and Spectral AI tied by winning 7 of the 14 factors compared between the two stocks.

How does IRIDEX compare to Sensus Healthcare?

Sensus Healthcare (NASDAQ:SRTS) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Sensus Healthcare presently has a consensus price target of $5.83, suggesting a potential upside of 64.78%. IRIDEX has a consensus price target of $3.00, suggesting a potential upside of 314.59%. Given IRIDEX's higher probable upside, analysts clearly believe IRIDEX is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	2.12	-$7.72M	-$0.94	N/A
IRIDEX	$52.67M	0.24	-$4.44M	-$0.20	N/A

IRIDEX has a net margin of -6.88% compared to Sensus Healthcare's net margin of -88.45%. IRIDEX's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
IRIDEX	-6.88%	N/A	-12.55%

Sensus Healthcare has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, meaning that its share price is 34% less volatile than the broader market.

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Sensus Healthcare had 13 more articles in the media than IRIDEX. MarketBeat recorded 14 mentions for Sensus Healthcare and 1 mentions for IRIDEX. Sensus Healthcare's average media sentiment score of 1.63 beat IRIDEX's score of 0.44 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Very Positive
IRIDEX	Neutral

Summary

Sensus Healthcare and IRIDEX tied by winning 8 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Precision Optics?

IRIDEX (NASDAQ:IRIX) and Precision Optics (NASDAQ:POCI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

IRIDEX has higher revenue and earnings than Precision Optics. Precision Optics is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.24	-$4.44M	-$0.20	N/A
Precision Optics	$19.09M	2.46	-$5.78M	-$0.63	N/A

In the previous week, IRIDEX and IRIDEX both had 1 articles in the media. Precision Optics' average media sentiment score of 1.89 beat IRIDEX's score of 0.44 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Neutral
Precision Optics	Very Positive

IRIDEX currently has a consensus price target of $3.00, suggesting a potential upside of 314.59%. Given IRIDEX's stronger consensus rating and higher probable upside, equities research analysts plainly believe IRIDEX is more favorable than Precision Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

IRIDEX has a net margin of -6.88% compared to Precision Optics' net margin of -17.03%. IRIDEX's return on equity of 0.00% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Precision Optics	-17.03%	-37.47%	-19.96%

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 14.4% of Precision Optics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IRIDEX has a beta of 0.66, suggesting that its stock price is 34% less volatile than the broader market. Comparatively, Precision Optics has a beta of 0.34, suggesting that its stock price is 66% less volatile than the broader market.

Summary

IRIDEX beats Precision Optics on 12 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 314.59%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Baird Medical Investment has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
IRIDEX	-6.88%	N/A	-12.55%

Baird Medical Investment has higher earnings, but lower revenue than IRIDEX.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	2.06	N/A	N/A	N/A
IRIDEX	$52.67M	0.24	-$4.44M	-$0.20	N/A

In the previous week, Baird Medical Investment and Baird Medical Investment both had 1 articles in the media. Baird Medical Investment's average media sentiment score of 1.87 beat IRIDEX's score of 0.44 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Overall Sentiment
Baird Medical Investment	Very Positive
IRIDEX	Neutral

Baird Medical Investment has a beta of -1.16, meaning that its stock price is 216% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 20.1% of IRIDEX shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 8.6% of IRIDEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

IRIDEX beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

How does IRIDEX compare to Sanuwave Health?

IRIDEX (NASDAQ:IRIX) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

IRIDEX has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.48, meaning that its stock price is 48% more volatile than the broader market.

In the previous week, Sanuwave Health had 1 more articles in the media than IRIDEX. MarketBeat recorded 2 mentions for Sanuwave Health and 1 mentions for IRIDEX. Sanuwave Health's average media sentiment score of 1.43 beat IRIDEX's score of 0.44 indicating that Sanuwave Health is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Neutral
Sanuwave Health	Positive

Sanuwave Health has lower revenue, but higher earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.24	-$4.44M	-$0.20	N/A
Sanuwave Health	$44.05M	0.92	$11.81M	$0.24	19.54

IRIDEX presently has a consensus target price of $3.00, suggesting a potential upside of 314.59%. Sanuwave Health has a consensus target price of $51.00, suggesting a potential upside of 987.42%. Given Sanuwave Health's stronger consensus rating and higher possible upside, analysts clearly believe Sanuwave Health is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sanuwave Health	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Sanuwave Health has a net margin of 32.38% compared to IRIDEX's net margin of -6.88%. Sanuwave Health's return on equity of 1,728.10% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Sanuwave Health	32.38%	1,728.10%	39.04%

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 8.6% of IRIDEX shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Sanuwave Health beats IRIDEX on 15 of the 16 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.41M	$5.83B	$7.20B	$12.89B
Dividend Yield	N/A	1.75%	2.54%	11.27%
P/E Ratio	-3.62	25.97	272.61	25.48
Price / Sales	0.24	71.60	626.66	97.10
Price / Cash	N/A	33.69	28.74	36.03
Price / Book	-12.06	6.24	11.05	6.34
Net Income	-$4.44M	$149.14M	$3.47B	$349.45M
7 Day Performance	1.06%	-0.61%	0.25%	-0.65%
1 Month Performance	-11.76%	6.50%	8.27%	4.48%
1 Year Performance	-46.00%	5.87%	24.14%	14.89%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	1.6785 of 5 stars	$0.72 +2.4%	$3.00 +314.6%	-46.0%	$12.41M	$52.67M	N/A	120
MDAI Spectral AI	2.9882 of 5 stars	$1.62 +0.3%	$4.00 +147.7%	-18.7%	$51.39M	$19.65M	N/A	83
SRTS Sensus Healthcare	3.4223 of 5 stars	$3.07 +2.2%	$5.83 +90.3%	+4.4%	$50.45M	$27.48M	N/A	40	News Coverage Insider Trade
POCI Precision Optics	0.9992 of 5 stars	$4.37 +0.7%	N/A	-8.5%	$47.83M	$28.94M	N/A	80	Gap Up
BDMD Baird Medical Investment	1.3124 of 5 stars	$1.12 +2.8%	N/A	-55.1%	$45.90M	$22.54M	N/A	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors

IRIX vs. MDAI, SRTS, POCI, BDMD, and SNWV

How does IRIDEX compare to Spectral AI?

Summary

How does IRIDEX compare to Sensus Healthcare?

Summary

How does IRIDEX compare to Precision Optics?

Summary

How does IRIDEX compare to Baird Medical Investment?

Summary

How does IRIDEX compare to Sanuwave Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IRIDEX (IRIX) Competitors

IRIX vs. MDAI, SRTS, POCI, BDMD, and SNWV

How does IRIDEX compare to Spectral AI?

Does the media refer more to IRIX or MDAI?

Do analysts recommend IRIX or MDAI?

Which has stronger valuation & earnings, IRIX or MDAI?

Do institutionals and insiders hold more shares of IRIX or MDAI?

Is IRIX or MDAI more profitable?

Which has more risk and volatility, IRIX or MDAI?

Summary

How does IRIDEX compare to Sensus Healthcare?

Do analysts rate SRTS or IRIX?

Which has higher valuation and earnings, SRTS or IRIX?

Is SRTS or IRIX more profitable?

Which has more risk and volatility, SRTS or IRIX?

Do institutionals & insiders have more ownership in SRTS or IRIX?

Does the media prefer SRTS or IRIX?

Summary

How does IRIDEX compare to Precision Optics?

Which has better valuation & earnings, IRIX or POCI?

Does the media favor IRIX or POCI?

Do analysts rate IRIX or POCI?

Is IRIX or POCI more profitable?

Do insiders and institutionals have more ownership in IRIX or POCI?

Which has more risk and volatility, IRIX or POCI?

Summary

How does IRIDEX compare to Baird Medical Investment?

Do analysts rate BDMD or IRIX?

Is BDMD or IRIX more profitable?

Which has better earnings & valuation, BDMD or IRIX?

Does the media prefer BDMD or IRIX?

Which has more risk & volatility, BDMD or IRIX?

Do institutionals and insiders hold more shares of BDMD or IRIX?

Summary

How does IRIDEX compare to Sanuwave Health?

Which has more volatility & risk, IRIX or SNWV?

Does the media favor IRIX or SNWV?

Which has better earnings & valuation, IRIX or SNWV?

Do analysts prefer IRIX or SNWV?

Is IRIX or SNWV more profitable?

Do insiders & institutionals believe in IRIX or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX vs. The Competition

IRIDEX Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools